NM_000036.3:c.382-6dupT

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP6

The NM_000036.3(AMPD1):​c.382-6dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0398 in 961,800 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.046 ( 0 hom. )

Consequence

AMPD1
NM_000036.3 splice_region, intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 1.05

Publications

0 publications found
Variant links:
Genes affected
AMPD1 (HGNC:468): (adenosine monophosphate deaminase 1) Adenosine monophosphate deaminase 1 catalyzes the deamination of AMP to IMP in skeletal muscle and plays an important role in the purine nucleotide cycle. Two other genes have been identified, AMPD2 and AMPD3, for the liver- and erythocyte-specific isoforms, respectively. Deficiency of the muscle-specific enzyme is apparently a common cause of exercise-induced myopathy and probably the most common cause of metabolic myopathy in the human. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]
AMPD1 Gene-Disease associations (from GenCC):
  • myopathy due to myoadenylate deaminase deficiency
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • adenosine monophosphate deaminase deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Variant has high frequency in the AFR (0.0494) population. However there is too low homozygotes in high coverage region: (expected more than 381, got 0).
BP6
Variant 1-114684369-C-CA is Benign according to our data. Variant chr1-114684369-C-CA is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 291934.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AMPD1NM_000036.3 linkc.382-6dupT splice_region_variant, intron_variant Intron 4 of 15 ENST00000520113.7 NP_000027.3 P23109-1
AMPD1NM_001172626.2 linkc.370-6dupT splice_region_variant, intron_variant Intron 3 of 14 NP_001166097.2 P23109-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AMPD1ENST00000520113.7 linkc.382-6_382-5insT splice_region_variant, intron_variant Intron 4 of 15 1 NM_000036.3 ENSP00000430075.3 P23109-1

Frequencies

GnomAD3 genomes
AF:
0.00114
AC:
153
AN:
134380
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00282
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000528
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000422
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00219
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000275
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0838
AC:
5918
AN:
70624
AF XY:
0.0853
show subpopulations
Gnomad AFR exome
AF:
0.0801
Gnomad AMR exome
AF:
0.100
Gnomad ASJ exome
AF:
0.0705
Gnomad EAS exome
AF:
0.0877
Gnomad FIN exome
AF:
0.0821
Gnomad NFE exome
AF:
0.0719
Gnomad OTH exome
AF:
0.0968
GnomAD4 exome
AF:
0.0461
AC:
38149
AN:
827386
Hom.:
0
Cov.:
0
AF XY:
0.0444
AC XY:
18359
AN XY:
413154
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0521
AC:
986
AN:
18918
American (AMR)
AF:
0.0466
AC:
1262
AN:
27064
Ashkenazi Jewish (ASJ)
AF:
0.0442
AC:
669
AN:
15148
East Asian (EAS)
AF:
0.0461
AC:
1046
AN:
22678
South Asian (SAS)
AF:
0.0361
AC:
1856
AN:
51378
European-Finnish (FIN)
AF:
0.0467
AC:
1533
AN:
32856
Middle Eastern (MID)
AF:
0.0360
AC:
143
AN:
3970
European-Non Finnish (NFE)
AF:
0.0467
AC:
28979
AN:
620930
Other (OTH)
AF:
0.0486
AC:
1675
AN:
34444
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.240
Heterozygous variant carriers
0
6440
12880
19321
25761
32201
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
1120
2240
3360
4480
5600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00113
AC:
152
AN:
134414
Hom.:
0
Cov.:
32
AF XY:
0.00128
AC XY:
83
AN XY:
64854
show subpopulations
African (AFR)
AF:
0.00281
AC:
103
AN:
36622
American (AMR)
AF:
0.000527
AC:
7
AN:
13284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3218
East Asian (EAS)
AF:
0.000424
AC:
2
AN:
4720
South Asian (SAS)
AF:
0.00143
AC:
6
AN:
4192
European-Finnish (FIN)
AF:
0.00219
AC:
17
AN:
7752
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
274
European-Non Finnish (NFE)
AF:
0.000275
AC:
17
AN:
61716
Other (OTH)
AF:
0.00
AC:
0
AN:
1818
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0543
Hom.:
0

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Muscle AMP deaminase deficiency Uncertain:1Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jun 12, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.0
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs727503806; hg19: chr1-115226990; COSMIC: COSV62417265; API